Bristol-Myers Squibb Company is a pharmaceutical company.
Bristol-Myers Squibb Company (BMY) is expected to report earnings on Thursday, October 29, 2026, before the open. Estimated release time 07:08 ET. Consensus EPS estimate is $1.10.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-07-30 | Jun 2026 qtr | $1.60 | $2.04 | — | $12.97B |
| 2026-04-30 | Mar 2026 qtr | $1.42 | $1.58 | +11.3% | $11.49B |
| 2026-02-05 | Dec 2025 qtr | $1.23 | $1.26 | +2.4% | $12.50B |
| 2025-10-30 | Sep 2025 qtr | $1.52 | $1.63 | +7.2% | $12.22B |
| 2025-07-31 | Jun 2025 qtr | $1.09 | $1.46 | — | $12.27B |
| 2025-04-24 | Mar 2025 qtr | $1.49 | $1.80 | — | $11.20B |
| 2025-02-06 | Dec 2024 qtr | $1.47 | $1.67 | +13.6% | $12.34B |
| 2024-10-31 | Sep 2024 qtr | $1.49 | $1.80 | — | $11.89B |
BMY has beaten consensus EPS in 4 of its last 4 scored quarters.
BMY pays a quarterly dividend, currently yielding 4.12%.
| Ex-dividend date | Amount | Paid |
|---|---|---|
| 2026-10-02 | $0.63 | 2026-11-02 |
| 2026-07-02 | $0.63 | 2026-08-03 |
| 2026-04-02 | $0.63 | 2026-05-01 |
| 2026-01-02 | $0.63 | 2026-02-02 |
| 2025-10-03 | $0.62 | 2025-11-03 |
| 2025-07-03 | $0.62 | 2025-08-01 |